Current role
David Shook
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Lyell Immunopharma, Inc. (LYEL)
Proxy statement
Current -
Nkarta, Inc. (NKTX)
Proxy statement
Current -
Nkarta, Inc. (NKTX)
Proxy statement
Start not stated–2025-06-06
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Nkarta, Inc.
Current role
NKTX
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Nkarta, Inc. (NKTX) | Chief Medical Officer, Head of Research and Development | $489,507 | $1,900,182 |
| 2023 | Nkarta, Inc. (NKTX) | Chief Medical Officer, Head of Research and Development | $459,800 | $1,510,050 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.